InsiderSource
GYRE

GYRE THERAPEUTICS, INC.

SEC CIK 1124105
$5.82 −26.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$866.9K
14 open-market
Net insider flow
−$866.9K
Net selling
Filings shown
32
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at GYRE have sold a net $866.9K of stock (0 open-market buys vs 14 sells).

Largest recent trade: Ye Weiguo sold $120K of GYRE, trimming their stake 3%.

Most active filer: Ye Weiguo, with 24 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for GYRE, newest first
View on SEC EDGAR ↗
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed 6d ago ΔOwn −0.9%

Ye Weiguo sold $39.9K of GYRE, trimming their stake 1%.

−$39.9K
6,418 sh @ $6
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed 6d ago ΔOwn −2.0%

Ye Weiguo sold $89K of GYRE, trimming their stake 2%.

−$89K
14,500 sh @ $6
Advertisement
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed 1w ago ΔOwn −2.2%

Ye Weiguo sold $98.6K of GYRE, trimming their stake 2%.

−$98.6K
15,401 sh @ $6
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed 1w ago ΔOwn −2.7%

Ye Weiguo sold $120K of GYRE, trimming their stake 3%.

−$120K
19,575 sh @ $6
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed 3w ago ΔOwn −0.6%

Ye Weiguo sold $24.4K of GYRE, trimming their stake 1%.

−$24.4K
4,000 sh @ $6
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed 3w ago ΔOwn −0.5%

Ye Weiguo sold $21.3K of GYRE.

−$21.3K
3,500 sh @ $6
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed 3w ago ΔOwn −1.8%

Ye Weiguo sold $78.8K of GYRE, trimming their stake 2%.

−$78.8K
12,820 sh @ $6
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed 3w ago ΔOwn −1.3%

Ye Weiguo sold $57.8K of GYRE, trimming their stake 1%.

−$57.8K
9,400 sh @ $6
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed 4w ago ΔOwn −1.3%

Ye Weiguo sold $58.1K of GYRE, trimming their stake 1%.

−$58.1K
9,120 sh @ $6
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed May 18, 2026 ΔOwn −1.8%

Ye Weiguo sold $87.1K of GYRE, trimming their stake 2%.

−$87.1K
13,100 sh @ $7
GYRE
GYRE THERAPEUTICS, INC.
Sell Ye Weiguo · Chief Operating Officer · Open-market sale · filed May 18, 2026 ΔOwn −2.2%

Ye Weiguo sold $107.7K of GYRE, trimming their stake 2%.

−$107.7K
15,580 sh @ $7
GYRE
GYRE THERAPEUTICS, INC.
Sell Luo Ying · Director, Chief Executive Officer · Open-market sale · filed May 7, 2026 ΔOwn −0.4%

Luo Ying sold $81.5K of GYRE.

−$81.5K
10,136 sh @ $8
GYRE
GYRE THERAPEUTICS, INC.
Sell Luo Ying · Director, Chief Executive Officer · Open-market sale · filed May 7, 2026

Luo Ying sold $1.4K of GYRE.

−$1.4K
179 sh @ $8
GYRE
GYRE THERAPEUTICS, INC.
Sell Ma Songjiang · Director, President · Open-market sale · filed May 29, 2025 ΔOwn −0.1%

Ma Songjiang sold $20.6K of GYRE.

−$20.6K
2,000 sh @ $10
GYRE
GYRE THERAPEUTICS, INC.
Sell Ma Songjiang · Director, President · Open-market sale · filed May 27, 2025 ΔOwn −0.1%

Ma Songjiang sold $21.9K of GYRE.

−$21.9K
2,000 sh @ $11
Advertisement

About GYRE insider activity

This page tracks every recent Form 4 filed for GYRE THERAPEUTICS, INC. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is GYRE insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for GYRE THERAPEUTICS, INC. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.